HALP score for predicting outcomes in upper GI bleeding
Part of Digestive system clinical trials.
This study checks whether a simple blood test score (called HALP) can help predict which people with upper gastrointestinal bleeding are more likely to have serious complications. The goal is to find patients who need closer monitoring or quicker treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with upper gastrointestinal bleeding during an endoscopy.
- You must have had certain blood tests (albumin, hemoglobin, platelets, and INR) taken at the emergency room.
- You must not be pregnant.
- You must have complete medical records for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a newer “OTSC” procedure works as well as a standard procedure called angiographic embolization to stop active, hard-to-control upper gastrointestinal bleeding. It may help people whose bleeding continues or comes back even after initial endoscopy treatment.
This study compares two ways of giving blood transfusions to people with upper digestive tract bleeding who are anemic. It aims to find out which approach is safer and more effective.
This study checks how well a risk score predicts the need for treatment in patients with upper gastrointestinal bleeding (bleeding in the stomach or esophagus). It may help doctors decide if you need urgent care.
This study aims to create a tool that helps doctors predict if a patient with upper gut bleeding (not from veins) will rebleed while still in the hospital. It uses information from your hospital stay to better understand your risk and improve care.
This study checks whether a score called CAGIB can accurately predict the risk of dying during the hospital stay for people with cirrhosis who have sudden bleeding in the digestive tract. It may help doctors identify who needs the most urgent care and monitor outcomes more accurately.
This study tests a small pill (HemoPill) that detects bleeding in the stomach or intestines during an upper endoscopy. It might help doctors find the source of bleeding more quickly and accurately.
Hear when a new Upper Gastrointestinal Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.